Catalyst Wire Dossier Catalyst Wire Dossier

FARAPULSE Endocardial Ablation System

· Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FARAPULSE Endocardial Ablation System, covering 2022-05-04 to 2022-05-04. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Feasibility Study of the FARAPULSE Endocardial Ablation System to Treat Paroxysmal Atrial Fibrillation [NA]

See pricing